MX385475B - Derivados de piridoquinazolina eficaces como inhibidores de proteina quinasa - Google Patents

Derivados de piridoquinazolina eficaces como inhibidores de proteina quinasa

Info

Publication number
MX385475B
MX385475B MX2019014436A MX2019014436A MX385475B MX 385475 B MX385475 B MX 385475B MX 2019014436 A MX2019014436 A MX 2019014436A MX 2019014436 A MX2019014436 A MX 2019014436A MX 385475 B MX385475 B MX 385475B
Authority
MX
Mexico
Prior art keywords
protein kinase
pyridoquinazoline
kinase inhibitors
derivatives useful
diseases
Prior art date
Application number
MX2019014436A
Other languages
English (en)
Spanish (es)
Other versions
MX2019014436A (es
Inventor
Guido Kurz
Gómez Juan Camacho
Original Assignee
Oncostellae S L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncostellae S L filed Critical Oncostellae S L
Publication of MX2019014436A publication Critical patent/MX2019014436A/es
Publication of MX385475B publication Critical patent/MX385475B/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F24HEATING; RANGES; VENTILATING
    • F24CDOMESTIC STOVES OR RANGES ; DETAILS OF DOMESTIC STOVES OR RANGES, OF GENERAL APPLICATION
    • F24C7/00Stoves or ranges heated by electric energy
    • F24C7/08Arrangement or mounting of control or safety devices
    • F24C7/082Arrangement or mounting of control or safety devices on ranges, e.g. control panels, illumination
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F24HEATING; RANGES; VENTILATING
    • F24CDOMESTIC STOVES OR RANGES ; DETAILS OF DOMESTIC STOVES OR RANGES, OF GENERAL APPLICATION
    • F24C7/00Stoves or ranges heated by electric energy
    • F24C7/08Arrangement or mounting of control or safety devices
    • F24C7/087Arrangement or mounting of control or safety devices of electric circuits regulating heat
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Combustion & Propulsion (AREA)
  • Mechanical Engineering (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MX2019014436A 2017-06-01 2018-05-31 Derivados de piridoquinazolina eficaces como inhibidores de proteina quinasa MX385475B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES201730759 2017-06-01
PCT/ES2018/070396 WO2018220252A1 (es) 2017-06-01 2018-05-31 Derivados de piridoquinazolina eficaces como inhibidores de proteína quinasa

Publications (2)

Publication Number Publication Date
MX2019014436A MX2019014436A (es) 2020-02-10
MX385475B true MX385475B (es) 2025-03-18

Family

ID=61569288

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019014436A MX385475B (es) 2017-06-01 2018-05-31 Derivados de piridoquinazolina eficaces como inhibidores de proteina quinasa

Country Status (22)

Country Link
US (1) US11021479B2 (https=)
EP (1) EP3632912B1 (https=)
JP (1) JP7110335B2 (https=)
KR (1) KR102629854B1 (https=)
CN (1) CN111247143B (https=)
AU (1) AU2018278283B2 (https=)
CA (1) CA3066009A1 (https=)
CY (1) CY1124087T1 (https=)
DK (1) DK3632912T3 (https=)
EA (1) EA037384B1 (https=)
ES (1) ES2881960T3 (https=)
HR (1) HRP20210814T1 (https=)
HU (1) HUE054792T2 (https=)
LT (1) LT3632912T (https=)
MX (1) MX385475B (https=)
PL (1) PL3632912T3 (https=)
PT (1) PT3632912T (https=)
RS (1) RS61833B1 (https=)
SI (1) SI3632912T1 (https=)
SM (1) SMT202100312T1 (https=)
WO (1) WO2018220252A1 (https=)
ZA (1) ZA201908372B (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE072013T2 (hu) 2020-01-31 2025-10-28 Lg Energy Solution Ltd Eljárás szervetlen többréteges szerkezetû szeparátor-kompozit elektróda elõállítására, és az azzal elõállított szeparátor-kompozit elektróda

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4551460A (en) 1982-05-10 1985-11-05 Hoffmann-La Roche Inc. Pyrido[2,1-b]quinazoline derivatives useful as agents for treatment of allergic conditions and vascular disorders involving thrombosis
WO1998023617A1 (en) * 1996-11-26 1998-06-04 American Cyanamid Company Hetero-biaryl-pyridoquinazolinone derivatives as anti-cancer agents
EP1684762A4 (en) * 2003-11-13 2009-06-17 Ambit Biosciences Corp UREA DERIVATIVES AS MODULATORS OF KINASE
WO2009086303A2 (en) * 2007-12-21 2009-07-09 University Of Rochester Method for altering the lifespan of eukaryotic organisms
WO2010061971A1 (ja) 2008-11-28 2010-06-03 興和株式会社 ピリジン-3-カルボキシアミド誘導体
EP3778600A1 (en) * 2014-03-20 2021-02-17 The Johns Hopkins University Compounds which inhibit rna polymerase, compositions including such compounds, and their use

Also Published As

Publication number Publication date
KR20200011990A (ko) 2020-02-04
SI3632912T1 (sl) 2021-08-31
CN111247143B (zh) 2022-07-05
US20200148676A1 (en) 2020-05-14
DK3632912T3 (da) 2021-05-10
JP2020521817A (ja) 2020-07-27
AU2018278283B2 (en) 2021-06-17
JP7110335B2 (ja) 2022-08-01
KR102629854B1 (ko) 2024-01-25
EP3632912B1 (en) 2021-03-17
MX2019014436A (es) 2020-02-10
SMT202100312T1 (it) 2021-07-12
PT3632912T (pt) 2021-06-02
CA3066009A1 (en) 2018-12-06
PL3632912T3 (pl) 2021-09-06
AU2018278283A1 (en) 2019-12-19
ES2881960T3 (es) 2021-11-30
LT3632912T (lt) 2021-06-10
US11021479B2 (en) 2021-06-01
RS61833B1 (sr) 2021-06-30
CN111247143A (zh) 2020-06-05
HUE054792T2 (hu) 2021-09-28
EP3632912A1 (en) 2020-04-08
EA201992793A1 (ru) 2020-03-26
CY1124087T1 (el) 2022-05-27
BR112019024892A2 (pt) 2020-06-16
HRP20210814T1 (hr) 2021-06-25
EA037384B1 (ru) 2021-03-23
WO2018220252A1 (es) 2018-12-06
ZA201908372B (en) 2021-04-28

Similar Documents

Publication Publication Date Title
MY208632A (en) Novel benzylamino substituted pyridopyrimidinones and derivatives as sos1 inhibitors
PH12019501941A1 (en) Jak inhibitors containing a 4-membered heterocyclic amide
MX2019014876A (es) Compuestos heteroaromaticos como inhibidores de vanina.
MY196909A (en) Boronic acid derivatives and therapeutic uses thereof
SA520412335B1 (ar) مشتقات أوكسي فلورو ببريدين كمثبط كيناز
GEP20207202B (en) Tyrosine amide derivatives as rho-kinase inhibitors
GEP20207105B (en) 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2yl carbamate derivatives as magl inhibitors
EA033343B1 (ru) Соединения, ингибирующие rip2-киназу, фармацевтическая композиция на их основе и их применение для лечения заболеваний, опосредуемых rip2-киназой
PH12019501811A1 (en) Novel heterocyclic compound, its preparation method, and pharmaceutical composition comprising the same
SA521422152B1 (ar) Vanin مركبات عطرية غير متجانسة كمثبطات
EP4371562A3 (en) 2-quinolone derived inhibitors of bcl6
PH12021550269A1 (en) Heteroaromatic compounds as vanin inhibitors
MX2020001531A (es) Nuevos compuestos hetorociclicos como inhibidores de cdk8/19.
SG10201907291QA (en) Monomethylfumarate prodrug compositions
PH12016502568A1 (en) Novel heterocyclic compound
PH12021550258A1 (en) Cdk8/19 inhibitors
MX2021006490A (es) Compuestos heteroaromaticos como inhibidores de vanina.
MX2019004822A (es) Derivado del pirazol 3,4-bipiridilo y metodo de preparacion del mismo y aplicacion medica del mismo.
MX385475B (es) Derivados de piridoquinazolina eficaces como inhibidores de proteina quinasa
MX2019014438A (es) Derivados de acidos carboxilicos eficaces como inhibidores de la proteina quinasa.
GB2553685A (en) Novel éthynylxanthines, their preparation and use as inhibitors of matrix metalloproteinases and angiogenesis